Global Magnetic Resonance Imaging (MRI) Market Research and Analysis, 2014-2020
MARKET INSIGHTS:
Global Magnetic Resonance Imaging (MRI) Market is expected to grow with a CAGR 6% during 2015-2020. Global Magnetic Resonance Imaging (MRI) Market is segmented on the basis of Application, Architecture, Field Strength and Geography. Global Magnetic Resonance Imaging (MRI) Market has varied and innovative products due to successful outcome of research and development and patents. Global Magnetic Resonance Imaging (MRI) Market by application includes Brain & Neurological MRI, Spine & Musculoskeletal MRI, Vascular MRI, Pelvic & Abdominal MRI, Breast MRI and Cardiac MRI. The pivotal factors for the modest growth of Global Magnetic Resonance Imaging (MRI) Market includes the significant adoption of diagnostic devices and hybrid operating rooms across the globe. Technological advancement and innovation boosted the MRI market across the globe.
Exploration through R&D is expected to bring technological advancement with enhancement in existing products. Rising life style oriented diseases such as Cancer, CVD, CHD, and other neurological diseases are expected to create huge demand for Global Magnetic Resonance Imaging (MRI) products. Global Magnetic Resonance Imaging (MRI) Market products, diagnosis and treatment are costly and may affect the market growth. However, the rising adoption of diagnostic devices and machines are expected to create huge demand for the MRI market. APAC region has less adoption and development in Global Magnetic Resonance Imaging (MRI) Market, however, with rise in healthcare spending and favorable government policies, APAC region is expected to create huge opportunity for the Global Magnetic Resonance Imaging (MRI) Market.
GEOGRAPHICAL INSIGHTS
North America generates highest revenues across the globe due to huge adoption of Global Magnetic Resonance Imaging (MRI) Market application has huge demand across the globe. North America has the highest rate of healthcare spending followed by Europe. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create huge opportunity for Global Magnetic Resonance Imaging (MRI) Market. Improved healthcare spending, infrastructure development and favorable government policies made APAC region an emerging economy with significant opportunity for stakeholders. The report includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Patent Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market. Competitive Insights:
GE Healthcare, Hologic Inc, Emergence Teleradiology, Planmed, Aurora Imaging Technology Inc, Fonar Corporation, Agilent Technologies are the key companies in the Global Magnetic Resonance Imaging (MRI) Market. Other major players profiled in the report include: Hitachi Medical Corporation, Medtronic Inc, Johnson & Johnson, Phillips Healthcare, Siemens Healthcare, Esoate S.P.A., Toshiba Medical Systems, Sectra, NCD Company, Shared Imaging, Amber Diagnostics, Neusoft Medical Systems Co. Ltd Imris Inc. Various corporate strategies such as launch of new products, R&D, partnership, mergers and acquisition are widely adopted by key players to stay competitive.
MARKET SEGMENTATION:
Global Magnetic Resonance Imaging (MRI) Market is segmented on the basis of application, architecture, field strength and region. Global Magnetic Resonance Imaging (MRI) Market by application and field strength has significant contribution in generating huge revenues across the globe. The Global Magnetic Resonance Imaging (MRI) Market by field strength such as low to mild, high field, very high field and ultra-high field are widely adopted across the globe.
Global Magnetic Resonance Imaging (MRI) Market is expected to grow with a CAGR 6% during 2015-2020. Global Magnetic Resonance Imaging (MRI) Market is segmented on the basis of Application, Architecture, Field Strength and Geography. Global Magnetic Resonance Imaging (MRI) Market has varied and innovative products due to successful outcome of research and development and patents. Global Magnetic Resonance Imaging (MRI) Market by application includes Brain & Neurological MRI, Spine & Musculoskeletal MRI, Vascular MRI, Pelvic & Abdominal MRI, Breast MRI and Cardiac MRI. The pivotal factors for the modest growth of Global Magnetic Resonance Imaging (MRI) Market includes the significant adoption of diagnostic devices and hybrid operating rooms across the globe. Technological advancement and innovation boosted the MRI market across the globe.
Exploration through R&D is expected to bring technological advancement with enhancement in existing products. Rising life style oriented diseases such as Cancer, CVD, CHD, and other neurological diseases are expected to create huge demand for Global Magnetic Resonance Imaging (MRI) products. Global Magnetic Resonance Imaging (MRI) Market products, diagnosis and treatment are costly and may affect the market growth. However, the rising adoption of diagnostic devices and machines are expected to create huge demand for the MRI market. APAC region has less adoption and development in Global Magnetic Resonance Imaging (MRI) Market, however, with rise in healthcare spending and favorable government policies, APAC region is expected to create huge opportunity for the Global Magnetic Resonance Imaging (MRI) Market.
GEOGRAPHICAL INSIGHTS
North America generates highest revenues across the globe due to huge adoption of Global Magnetic Resonance Imaging (MRI) Market application has huge demand across the globe. North America has the highest rate of healthcare spending followed by Europe. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create huge opportunity for Global Magnetic Resonance Imaging (MRI) Market. Improved healthcare spending, infrastructure development and favorable government policies made APAC region an emerging economy with significant opportunity for stakeholders. The report includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Patent Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market. Competitive Insights:
GE Healthcare, Hologic Inc, Emergence Teleradiology, Planmed, Aurora Imaging Technology Inc, Fonar Corporation, Agilent Technologies are the key companies in the Global Magnetic Resonance Imaging (MRI) Market. Other major players profiled in the report include: Hitachi Medical Corporation, Medtronic Inc, Johnson & Johnson, Phillips Healthcare, Siemens Healthcare, Esoate S.P.A., Toshiba Medical Systems, Sectra, NCD Company, Shared Imaging, Amber Diagnostics, Neusoft Medical Systems Co. Ltd Imris Inc. Various corporate strategies such as launch of new products, R&D, partnership, mergers and acquisition are widely adopted by key players to stay competitive.
MARKET SEGMENTATION:
Global Magnetic Resonance Imaging (MRI) Market is segmented on the basis of application, architecture, field strength and region. Global Magnetic Resonance Imaging (MRI) Market by application and field strength has significant contribution in generating huge revenues across the globe. The Global Magnetic Resonance Imaging (MRI) Market by field strength such as low to mild, high field, very high field and ultra-high field are widely adopted across the globe.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PATENT ANALYSIS
2.6. ANALYST INSIGHT
2.6.1. KEY FINDINGS
2.6.2. RECOMMENDATION
2.6.3. CONCLUSION
2.7. PARAMETRIC ANALYSIS
2.7.1. INCIDENCE AND PREVALENCE RATE OF NEUROLOGICAL DISORDERS
2.7.2. INCIDENCE AND PREVALENCE RATE OF GERIATRIC POPULATION
2.7.3. INCIDENCE AND PREVALENCE RATE OF CANCER
2.7.4. INCIDENCE AND PREVALENCE RATE OF CVD
2.7.5. DIAGNOSTIC CENTRES ACROSS HOSPITALS AND CLINICS
2.8. REGULATION
2.8.1. REGULATIONS ON CLINICAL TRIALS
2.8.1.1.1. UNITED STATES
2.8.1.1.2. EUROPEAN UNION
2.8.1.1.3. CHINA
2.8.1.1.4. INDIA
2.8.1.1.5. REST OF THE WORLD
2.8.1.2. DRUG AND DEVICE REGULATIONS
2.8.1.2.1. UNITED STATES
2.8.1.2.2. EUROPEAN UNION
2.8.1.2.3. CHINA
2.8.1.2.4. INDIA
2.8.1.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING NEUROLOGICAL DISEASES ARE EXPECTED TO DRIVE MRI SYSTEM MARKET
3.1.2. RISING ADOPTION OF DIAGNOSTICS SYSTEM ENABLES THE GLOBAL MRI SYSTEM MARKET TO GROW
3.1.3. TECHNOLOGICAL ADVANCEMENT AND INNOVATION IN MAGNETIC RESONANCE IMAGING (MRI)
3.1.4. RISE IN ADOPTION OF HYBRID OPERATING ROOMS
3.1.5. RISING HEALTHCARE SPENDING AND R&D SPENDING CREATE HUGE SCOPE FOR THE MARKET
3.1.6. GLOBAL RISE IN CANCER, CVD AND OTHER LIFE STYLE ORIENTED DISEASES DRIVING THE GLOBAL MRI SYSTEM MARKET
3.1.7. RESEARCH & DEVELOPMENT TO DRIVE THE GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET
3.2. RESTRAINT
3.2.1. HIGH COST OF MRI MACHINES MAY AFFECT THE MARKET
3.2.2. REIMBURSEMENT POLICIES MAY AFFECT THE GLOBAL MRI SYSTEM MARKET
3.2.3. STRINGENT GOVERNMENT POLICIES AND REGULATIONS ARE CHALLENGING
3.3. OPPORTUNITY
3.3.1. ROBOTIC AUTOMATION WILL FURTHER CUT THE COST OF MAGNETIC RESONANCE IMAGING (MRI) ANALYSIS
3.3.2. DIAGNOSTIC MARKET IS EXPECTED TO GROW SIGNIFICANTLY IN THE NEXT FEW YEARS
3.3.3. UNTAPPED APAC REGION HAS HUGE SCOPE FOR GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET
MARKET SEGMENTATION
4.1. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2014-2020,($ MILLIONS)
4.1.1. GLOBAL BRAIN AND NEUROLOGICAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.2. GLOBAL SPINE AND MUSCULOSKELETAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.3. GLOBAL SPINE AND MUSCULOSKELETAL MRI RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.4. GLOBAL VASCULAR MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.5. GLOBAL VASCULAR MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.6. GLOBAL PELVIC AND ABDOMINAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.7. GLOBAL BREAST MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.8. GLOBAL CARDIAC MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.2. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY ARCHITECTURE 2014-2020,($ MILLIONS)
4.2.1. GLOBAL CLOSED MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.2.2. GLOBAL OPEN MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.3. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY FIELD STRENGTH 2014-2020, ($ MILLIONS)
4.3.1. GLOBAL LOW TO MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.3.2. GLOBAL HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.3.3. GLOBAL VERY HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.3.4. GLOBAL ULTRA HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
6.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
7.1. GE HEALTHCARE
7.1.1. INTRODUCTION
7.1.2. GE HEALTHCARE PRODUCT PORTFOLIO
7.1.3. GE HEALTHCARE RECENT ACTIVITIES
7.1.4. GE HEALTHCARE SWOT ANALYSIS
7.2. AGILENT TECHNOLOGIES, INC.
7.2.1. INTRODUCTION
7.2.2. AGILENT TECHNOLOGIES INC PRODUCT PORTFOLIO
7.2.3. AGILENT TECHNOLOGIES INC RECENT ACTIVITIES
7.2.4. AGILENT TECHNOLOGIES INC SWOT ANALYSIS
7.3. HOLOGIC INC
7.3.1. INTRODUCTION
7.3.2. HOLOGIC INC PRODUCT PORTFOLIO
7.3.3. HOLOGIC INC COMPANY INC RECENT ACTIVITIES
7.3.4. HOLOGIC INC SWOT ANALYSIS
7.4. EMERGENCE TELERADIOLOGY
7.4.1. INTRODUCTION
7.4.2. EMERGENCE TELERADIOLOGY PRODUCT PORTFOLIO
7.4.3. EMERGENCE TELERADIOLOGY RECENT ACTIVITIES
7.4.4. EMERGENCE TELERADIOLOGY SWOT ANALYSIS
7.5. PLANMED
7.5.1. INTRODUCTION
7.5.2. PLANMED COMPANY PRODUCT PORTFOLIO
7.5.3. PLANMED COMPANY RECENT ACTIVITIES
7.5.4. PLANMED COMPANY SWOT ANALYSIS
7.6. AURORA IMAGING TECHNOLOGY INC
7.6.1. INTRODUCTION
7.6.2. AURORA IMAGING TECHNOLOGY INC PRODUCT PORTFOLIO
7.6.3. AURORA IMAGING TECHNOLOGY INC RECENT ACTIVITIES
7.6.4. AURORA IMAGING TECHNOLOGY INC SWOT ANALYSIS
7.7. ESOATE S.P.A.
7.7.1. INTRODUCTION
7.7.2. ESOATE S.P.A. PRODUCT PORTFOLIO
7.7.3. ESOATE S.P.A. RECENT ACTIVITIES
7.7.4. ESOATE S.P.A. SWOT ANALYSIS
7.8. FONAR CORPORATION
7.8.1. INTRODUCTION
7.8.2. FONAR CORPORATION PRODUCT PORTFOLIO
7.8.3. FONAR CORPORATION RECENT ACTIVITIES
7.8.4. FONAR CORPORATION SWOT ANALYSIS
7.9. HITACHI MEDICAL CORPORATION
7.9.1. INTRODUCTION
7.9.2. HITACHI MEDICAL CORPORATION PRODUCT PORTFOLIO
7.9.3. HITACHI MEDICAL CORPORATION RECENT ACTIVITIES
7.9.4. HITACHI MEDICAL CORPORATION SWOT ANALYSIS
7.10. MEDTRONIC INC
7.10.1. INTRODUCTION
7.10.2. MEDTRONIC INC PRODUCT PORTFOLIO
7.10.3. MEDTRONIC INC RECENT ACTIVITIES
7.10.4. MEDTRONIC INC SWOT ANALYSIS
7.11. JOHNSON & JOHNSON
7.11.1. INTRODUCTION
7.11.2. JOHNSON & JOHNSON PRODUCT PORTFOLIO
7.11.3. JOHNSON & JOHNSON RECENT ACTIVITIES
7.11.4. JOHNSON & JOHNSON SWOT ANALYSIS
7.12. NEUSOFT MEDICAL SYSTEMS CO. LTD
7.12.1. INTRODUCTION
7.12.2. NEUSOFT MEDICAL SYSTEMS CO. LTD PRODUCT PORTFOLIO
7.12.3. NEUSOFT MEDICAL SYSTEMS CO. LTD RECENT ACTIVITIES
7.12.4. NEUSOFT MEDICAL SYSTEMS CO. LTD SWOT ANALYSIS
7.13. PHILIPS HEALTHCARE
7.13.1. INTRODUCTION
7.13.2. PHILIPS HEALTHCARE PRODUCT PORTFOLIO
7.13.3. PHILIPS HEALTHCARE RECENT ACTIVITIES
7.13.4. PHILIPS HEALTHCARE SWOT ANALYSIS
7.14. SIEMENS HEALTHCARE
7.14.1. INTRODUCTION
7.14.2. SIEMENS HEALTHCARE PRODUCT PORTFOLIO
7.14.3. SIEMENS HEALTHCARE RECENT ACTIVITIES
7.14.4. SIEMENS HEALTHCARE SWOT ANALYSIS
7.15. TOSHIBA MEDICAL SYSTEMS
7.15.1. INTRODUCTION
7.15.2. TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO
7.15.3. TOSHIBA MEDICAL SYSTEMS RECENT ACTIVITIES
7.15.4. TOSHIBA MEDICAL SYSTEMS SWOT ANALYSIS
7.16. SECTRA
7.16.1. INTRODUCTION
7.16.2. SECTRA PORTFOLIO
7.16.3. SECTRA RECENT ACTIVITIES
7.16.4. SECTRA SWOT ANALYSIS
7.17. NCD COMPANY
7.17.1. INTRODUCTION
7.17.2. NCD COMPANY PRODUCT PORTFOLIO
7.17.3. NCD COMPANY RECENT ACTIVITIES
7.17.4. NCD COMPANY SWOT ANALYSIS
7.18. SHARED IMAGING
7.18.1. INTRODUCTION
7.18.2. SHARED IMAGING PRODUCT PORTFOLIO
7.18.3. SHARED IMAGING RECENT ACTIVITIES
7.18.4. SHARED IMAGING SWOT ANALYSIS
7.19. AMBER DIAGNOSTICS
7.19.1. INTRODUCTION
7.19.2. AMBER DIAGNOSTICS PRODUCT PORTFOLIO
7.19.3. NEUSOFT MEDICAL SYSTEMS CO. LTD RECENT ACTIVITIES
7.19.4. NEUSOFT MEDICAL SYSTEMS CO. LTD SWOT ANALYSIS
7.20. IMRIS INC
7.20.1. INTRODUCTION
7.20.2. IMRIS INC PRODUCT PORTFOLIO
7.20.3. IMRIS INC RECENT ACTIVITIES
7.20.4. IMRIS INC SWOT ANALYSIS
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PATENT ANALYSIS
2.6. ANALYST INSIGHT
2.6.1. KEY FINDINGS
2.6.2. RECOMMENDATION
2.6.3. CONCLUSION
2.7. PARAMETRIC ANALYSIS
2.7.1. INCIDENCE AND PREVALENCE RATE OF NEUROLOGICAL DISORDERS
2.7.2. INCIDENCE AND PREVALENCE RATE OF GERIATRIC POPULATION
2.7.3. INCIDENCE AND PREVALENCE RATE OF CANCER
2.7.4. INCIDENCE AND PREVALENCE RATE OF CVD
2.7.5. DIAGNOSTIC CENTRES ACROSS HOSPITALS AND CLINICS
2.8. REGULATION
2.8.1. REGULATIONS ON CLINICAL TRIALS
2.8.1.1.1. UNITED STATES
2.8.1.1.2. EUROPEAN UNION
2.8.1.1.3. CHINA
2.8.1.1.4. INDIA
2.8.1.1.5. REST OF THE WORLD
2.8.1.2. DRUG AND DEVICE REGULATIONS
2.8.1.2.1. UNITED STATES
2.8.1.2.2. EUROPEAN UNION
2.8.1.2.3. CHINA
2.8.1.2.4. INDIA
2.8.1.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING NEUROLOGICAL DISEASES ARE EXPECTED TO DRIVE MRI SYSTEM MARKET
3.1.2. RISING ADOPTION OF DIAGNOSTICS SYSTEM ENABLES THE GLOBAL MRI SYSTEM MARKET TO GROW
3.1.3. TECHNOLOGICAL ADVANCEMENT AND INNOVATION IN MAGNETIC RESONANCE IMAGING (MRI)
3.1.4. RISE IN ADOPTION OF HYBRID OPERATING ROOMS
3.1.5. RISING HEALTHCARE SPENDING AND R&D SPENDING CREATE HUGE SCOPE FOR THE MARKET
3.1.6. GLOBAL RISE IN CANCER, CVD AND OTHER LIFE STYLE ORIENTED DISEASES DRIVING THE GLOBAL MRI SYSTEM MARKET
3.1.7. RESEARCH & DEVELOPMENT TO DRIVE THE GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET
3.2. RESTRAINT
3.2.1. HIGH COST OF MRI MACHINES MAY AFFECT THE MARKET
3.2.2. REIMBURSEMENT POLICIES MAY AFFECT THE GLOBAL MRI SYSTEM MARKET
3.2.3. STRINGENT GOVERNMENT POLICIES AND REGULATIONS ARE CHALLENGING
3.3. OPPORTUNITY
3.3.1. ROBOTIC AUTOMATION WILL FURTHER CUT THE COST OF MAGNETIC RESONANCE IMAGING (MRI) ANALYSIS
3.3.2. DIAGNOSTIC MARKET IS EXPECTED TO GROW SIGNIFICANTLY IN THE NEXT FEW YEARS
3.3.3. UNTAPPED APAC REGION HAS HUGE SCOPE FOR GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET
MARKET SEGMENTATION
4.1. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2014-2020,($ MILLIONS)
4.1.1. GLOBAL BRAIN AND NEUROLOGICAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.2. GLOBAL SPINE AND MUSCULOSKELETAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.3. GLOBAL SPINE AND MUSCULOSKELETAL MRI RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.4. GLOBAL VASCULAR MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.5. GLOBAL VASCULAR MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.6. GLOBAL PELVIC AND ABDOMINAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.7. GLOBAL BREAST MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.1.8. GLOBAL CARDIAC MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.2. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY ARCHITECTURE 2014-2020,($ MILLIONS)
4.2.1. GLOBAL CLOSED MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.2.2. GLOBAL OPEN MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.3. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY FIELD STRENGTH 2014-2020, ($ MILLIONS)
4.3.1. GLOBAL LOW TO MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.3.2. GLOBAL HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.3.3. GLOBAL VERY HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
4.3.4. GLOBAL ULTRA HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
6.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANY PROFILES
7.1. GE HEALTHCARE
7.1.1. INTRODUCTION
7.1.2. GE HEALTHCARE PRODUCT PORTFOLIO
7.1.3. GE HEALTHCARE RECENT ACTIVITIES
7.1.4. GE HEALTHCARE SWOT ANALYSIS
7.2. AGILENT TECHNOLOGIES, INC.
7.2.1. INTRODUCTION
7.2.2. AGILENT TECHNOLOGIES INC PRODUCT PORTFOLIO
7.2.3. AGILENT TECHNOLOGIES INC RECENT ACTIVITIES
7.2.4. AGILENT TECHNOLOGIES INC SWOT ANALYSIS
7.3. HOLOGIC INC
7.3.1. INTRODUCTION
7.3.2. HOLOGIC INC PRODUCT PORTFOLIO
7.3.3. HOLOGIC INC COMPANY INC RECENT ACTIVITIES
7.3.4. HOLOGIC INC SWOT ANALYSIS
7.4. EMERGENCE TELERADIOLOGY
7.4.1. INTRODUCTION
7.4.2. EMERGENCE TELERADIOLOGY PRODUCT PORTFOLIO
7.4.3. EMERGENCE TELERADIOLOGY RECENT ACTIVITIES
7.4.4. EMERGENCE TELERADIOLOGY SWOT ANALYSIS
7.5. PLANMED
7.5.1. INTRODUCTION
7.5.2. PLANMED COMPANY PRODUCT PORTFOLIO
7.5.3. PLANMED COMPANY RECENT ACTIVITIES
7.5.4. PLANMED COMPANY SWOT ANALYSIS
7.6. AURORA IMAGING TECHNOLOGY INC
7.6.1. INTRODUCTION
7.6.2. AURORA IMAGING TECHNOLOGY INC PRODUCT PORTFOLIO
7.6.3. AURORA IMAGING TECHNOLOGY INC RECENT ACTIVITIES
7.6.4. AURORA IMAGING TECHNOLOGY INC SWOT ANALYSIS
7.7. ESOATE S.P.A.
7.7.1. INTRODUCTION
7.7.2. ESOATE S.P.A. PRODUCT PORTFOLIO
7.7.3. ESOATE S.P.A. RECENT ACTIVITIES
7.7.4. ESOATE S.P.A. SWOT ANALYSIS
7.8. FONAR CORPORATION
7.8.1. INTRODUCTION
7.8.2. FONAR CORPORATION PRODUCT PORTFOLIO
7.8.3. FONAR CORPORATION RECENT ACTIVITIES
7.8.4. FONAR CORPORATION SWOT ANALYSIS
7.9. HITACHI MEDICAL CORPORATION
7.9.1. INTRODUCTION
7.9.2. HITACHI MEDICAL CORPORATION PRODUCT PORTFOLIO
7.9.3. HITACHI MEDICAL CORPORATION RECENT ACTIVITIES
7.9.4. HITACHI MEDICAL CORPORATION SWOT ANALYSIS
7.10. MEDTRONIC INC
7.10.1. INTRODUCTION
7.10.2. MEDTRONIC INC PRODUCT PORTFOLIO
7.10.3. MEDTRONIC INC RECENT ACTIVITIES
7.10.4. MEDTRONIC INC SWOT ANALYSIS
7.11. JOHNSON & JOHNSON
7.11.1. INTRODUCTION
7.11.2. JOHNSON & JOHNSON PRODUCT PORTFOLIO
7.11.3. JOHNSON & JOHNSON RECENT ACTIVITIES
7.11.4. JOHNSON & JOHNSON SWOT ANALYSIS
7.12. NEUSOFT MEDICAL SYSTEMS CO. LTD
7.12.1. INTRODUCTION
7.12.2. NEUSOFT MEDICAL SYSTEMS CO. LTD PRODUCT PORTFOLIO
7.12.3. NEUSOFT MEDICAL SYSTEMS CO. LTD RECENT ACTIVITIES
7.12.4. NEUSOFT MEDICAL SYSTEMS CO. LTD SWOT ANALYSIS
7.13. PHILIPS HEALTHCARE
7.13.1. INTRODUCTION
7.13.2. PHILIPS HEALTHCARE PRODUCT PORTFOLIO
7.13.3. PHILIPS HEALTHCARE RECENT ACTIVITIES
7.13.4. PHILIPS HEALTHCARE SWOT ANALYSIS
7.14. SIEMENS HEALTHCARE
7.14.1. INTRODUCTION
7.14.2. SIEMENS HEALTHCARE PRODUCT PORTFOLIO
7.14.3. SIEMENS HEALTHCARE RECENT ACTIVITIES
7.14.4. SIEMENS HEALTHCARE SWOT ANALYSIS
7.15. TOSHIBA MEDICAL SYSTEMS
7.15.1. INTRODUCTION
7.15.2. TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO
7.15.3. TOSHIBA MEDICAL SYSTEMS RECENT ACTIVITIES
7.15.4. TOSHIBA MEDICAL SYSTEMS SWOT ANALYSIS
7.16. SECTRA
7.16.1. INTRODUCTION
7.16.2. SECTRA PORTFOLIO
7.16.3. SECTRA RECENT ACTIVITIES
7.16.4. SECTRA SWOT ANALYSIS
7.17. NCD COMPANY
7.17.1. INTRODUCTION
7.17.2. NCD COMPANY PRODUCT PORTFOLIO
7.17.3. NCD COMPANY RECENT ACTIVITIES
7.17.4. NCD COMPANY SWOT ANALYSIS
7.18. SHARED IMAGING
7.18.1. INTRODUCTION
7.18.2. SHARED IMAGING PRODUCT PORTFOLIO
7.18.3. SHARED IMAGING RECENT ACTIVITIES
7.18.4. SHARED IMAGING SWOT ANALYSIS
7.19. AMBER DIAGNOSTICS
7.19.1. INTRODUCTION
7.19.2. AMBER DIAGNOSTICS PRODUCT PORTFOLIO
7.19.3. NEUSOFT MEDICAL SYSTEMS CO. LTD RECENT ACTIVITIES
7.19.4. NEUSOFT MEDICAL SYSTEMS CO. LTD SWOT ANALYSIS
7.20. IMRIS INC
7.20.1. INTRODUCTION
7.20.2. IMRIS INC PRODUCT PORTFOLIO
7.20.3. IMRIS INC RECENT ACTIVITIES
7.20.4. IMRIS INC SWOT ANALYSIS
LIST OF TABLES
TABLE # 1 GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2014-2020,($ MILLIONS)
TABLE # 2 GLOBAL BRAIN AND NEUROLOGICAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 3 GLOBAL SPINE AND MUSCULOSKELETAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 4 GLOBAL SPINE AND MUSCULOSKELETAL MRI RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 5 GLOBAL VASCULAR MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 6 GLOBAL VASCULAR MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 7 GLOBAL PELVIC AND ABDOMINAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 8 GLOBAL BREAST MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 9 GLOBAL CARDIAC MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 10 GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY ARCHITECTURE 2014-2020,($ MILLIONS)
TABLE # 11 GLOBAL CLOSED MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 12 GLOBAL OPEN MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 13 GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY FIELD STRENGTH 2014-2020, ($ MILLIONS)
TABLE # 14 GLOBAL LOW TO MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 15 GLOBAL HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 16 GLOBAL VERY HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 17 GLOBAL ULTRA HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 1 GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2014-2020,($ MILLIONS)
TABLE # 2 GLOBAL BRAIN AND NEUROLOGICAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 3 GLOBAL SPINE AND MUSCULOSKELETAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 4 GLOBAL SPINE AND MUSCULOSKELETAL MRI RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 5 GLOBAL VASCULAR MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 6 GLOBAL VASCULAR MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 7 GLOBAL PELVIC AND ABDOMINAL MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 8 GLOBAL BREAST MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 9 GLOBAL CARDIAC MRI MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 10 GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY ARCHITECTURE 2014-2020,($ MILLIONS)
TABLE # 11 GLOBAL CLOSED MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 12 GLOBAL OPEN MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 13 GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET RESEARCH AND ANALYSIS, BY FIELD STRENGTH 2014-2020, ($ MILLIONS)
TABLE # 14 GLOBAL LOW TO MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 15 GLOBAL HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 16 GLOBAL VERY HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
TABLE # 17 GLOBAL ULTRA HIGH MILD FIELD MRI SYSTEMS MARKET RESEARCH AND ANALYSIS, 2014-2020,($ MILLIONS)
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. GE HEALTHCARE
2. AGILENT TECHNOLOGIES, INC.
3. HOLOGIC INC
4. EMERGENCE TELERADIOLOGY
5. PLANMED
6. AURORA IMAGING TECHNOLOGY INC
7. ESOATE S.P.A.
8. FONAR CORPORATION
9. HITACHI MEDICAL CORPORATION
10. MEDTRONIC INC
11. JOHNSON & JOHNSON
12. NEUSOFT MEDICAL SYSTEMS CO. LTD
13. PHILIPS HEALTHCARE
14. SIEMENS HEALTHCARE
15. TOSHIBA MEDICAL SYSTEMS
16. SECTRA
17. NCD COMPANY
18. SHARED IMAGING
19. AMBER DIAGNOSTICS
20. IMRIS INC
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2014-2020
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2014-2020
COMPANIES MENTIONED
1. GE HEALTHCARE
2. AGILENT TECHNOLOGIES, INC.
3. HOLOGIC INC
4. EMERGENCE TELERADIOLOGY
5. PLANMED
6. AURORA IMAGING TECHNOLOGY INC
7. ESOATE S.P.A.
8. FONAR CORPORATION
9. HITACHI MEDICAL CORPORATION
10. MEDTRONIC INC
11. JOHNSON & JOHNSON
12. NEUSOFT MEDICAL SYSTEMS CO. LTD
13. PHILIPS HEALTHCARE
14. SIEMENS HEALTHCARE
15. TOSHIBA MEDICAL SYSTEMS
16. SECTRA
17. NCD COMPANY
18. SHARED IMAGING
19. AMBER DIAGNOSTICS
20. IMRIS INC
